AAAAAA

   
Results: 1-14 |
Results: 14

Authors: ROTH AD MAIBACH R MORANT R PAGANI O DEBRAUD F BORNER MM STUPP R HERRMANN R FAZIO N SESSA C GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY, Annals of oncology, 9, 1998, pp. 232-232

Authors: FEY MF BLASER M WERNLI M JOTTERAND M MAIBACH R GRATWOHL A TOBLER A
Citation: Mf. Fey et al., SAMPLING BIAS AND LOGISTICAL PROBLEMS OF MOLECULAR ANALYSES IN A CLINICAL LEUKEMIA TRIAL, British Journal of Haematology, 103(2), 1998, pp. 585-587

Authors: LAFFER U HARDER F JAGGI P METZGER U AEBERHARD P EGELI R ARMA S BARRAS JP LAMPERT VD MARTINOLI S MULLER W SCHRODER R VONHUBEN R WEBER W CASTIGLIONE M GOLDHIRSCH A MAIBACH R SCHMITZ SFH GLOOR F STAMM B WALTZER U
Citation: U. Laffer et al., ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER, The European journal of surgery, 163(9), 1997, pp. 693-701

Authors: HOIGNE R ZOPPI M FISCHERTOROK M HUNZIKER T WEISS M ZEHNDER D HESS T MUELLER U NEFTEL KA GALEAZZI RL MAIBACH R
Citation: R. Hoigne et al., FROM SIGNAL GENERATION TO PROOF OF NEW DRUG EVENT COMBINATIONS IN THECOMPREHENSIVE HOSPITAL DRUG-MONITORING, BERNE-ST-GALLEN, 1974-1993 - 4 EXAMPLES, Pharmacoepidemiology and drug safety, 6, 1997, pp. 21-25

Authors: ROTH AD MAIBACH R MARTINELLI G FAZIO N PAGANI O MORANT R BORNER MM HERRMANN R HONEGGER HP CAVALLI F ALBERTO P CASTIGLIONE M GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN (TC) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PROMISING DRUG-COMBINATION, European journal of cancer, 33, 1997, pp. 1245-1245

Authors: SENN HJ MAIBACH R CASTIGLIONE M JUNGI WF CAVALLI F LEYVRAZ S OBRECHT JP SCHILDKNECHT O SIEGENTHALER P
Citation: Hj. Senn et al., ADJUVANT CHEMOTHERAPY IN OPERABLE BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS CHLORAMBUCIL, METHOTREXATE, AND FLUOROURACIL-11-YEAR RESULTS OF SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH TRIAL SAKK-27 82/, Journal of clinical oncology, 15(7), 1997, pp. 2502-2509

Authors: CASTIGLIONEGERTSCH M GOLDHIRSCH A GUSTERSON B BETTELHEIM R REED R GUSSET H GEISER K HURNY C BERNHARD J HANGARTNER A MAIBACH R PEDOWSKI R GELBER R PRICE K PETERSON H ZELEN M ISLEY M HINKLE R KAY RG HOLDAWAY IM HARVEY VJ JAGUSCH MF NEAVE L MASON BM EVANS B BENJAMIN CS CARTER JF GILLMAN JC MACK D BENSONCOOPER D MONFARDINI S GALLIGIONI E CRIVELLARI D BUONADONNA A MASSARUT S ROSSI C CANDIANI E CARBONE A VOLPE R TROVO MG RONCADIN M SANTINI GF VILLALTA D CORAN F MORASSUT S MARINI G SIMONCINI E MARPICATI P ZANIBONI A SARTORI U BARNI A CERUTTI L ALGHISI A RAFFAGLIO E GARATTINI MP ALBERTINI A GRIGOLATO F MORASSI L BERGONZINI R LAURIOLA C GUDGEON A DENT DM TILTMAN A HACKING A DOWDLE E STEYNOR P TOOP J SCHNURCH HG MOSNY D BENDER HG BOJAR H VERONESI A FOLADORE S PAMICH G BIANCHI G TORRETTA A RUDENSTAM CM WALLGREN A PERSSON S MATTSSON J CAHLIN E HAFSTROM LO HOLMBERG S HULTBORN R COLLDAHLJADERSTROM G GUSTAVSSON B CARLSSON G IVARSSON L THOREN O RUUSVIK O NICKLASSON LG DAHLIN S KARLSSON G LINDBERG B SUNDBACK A BERGEGARDH S SALANDER H ANDERSSON C HESSMAN Y NELZEN O HEIDEMAN M RAMHULT T SVENSSON JH LIDBERG P BJORK S LINDTNER J ERZEN D CERAR O STABUC B GOLOUH R LAMOVEC J SEBEK S KRAMBERGER M VRHOVEC I CORTESFUNES H MARTINEZTELLO F MENDIOLA C CRUZVIGO F LARRODERA ML SIERRA A MIRANDA P ALONSO S COLLINS J SNYDER R GREGORY P BURAS WI GREEN M GALE T HENDERSON M HART S NEIL S KITCHEN P LOVELL R MCLENNAN R REED R RUSSELL I SCHWARZ M BASSER R ROBERTSON A GILL P CARTER ML MALYCHA P YEOH E WARD G LEONG ASY LOMMAXSMITH J HOOSFALL D DANGELO R BYRNE M VANHAZEL G DEWAR J BUCK M SHEINER HJ INGRAM D STERRETT G HAHNEL R FORBES JF STEWARD J DARBAR SW BISHOP JM SIMMS B ZIOGAS V TATTERSALL MHN COATES A NIESCHE F WEST R RENWICK S DONOVAN J DUVAL P SIMES RJ NG A GLENN D NORTH RA BEITH J OCONNOR RG RICE M STEVENS G FEY M BARTH A DREHER E ISENSCHMID M SCHNEIDER H BUSER K LUDIN J LUTHI JM ALTERMATT HJ LAISSUE JA MARKWALDER R BURGI H SENN HJ THURLIMANN B JUNGI WF MORANT R OEHLSCHLEGEL C HARDMEIER T LUSCHER K RIES G TOPFER M LORENZ U BENZ D SCHILTKNECHT O SPATI B SCHMID L CAVALLI F SESSA C BRONZ L MARTINELLI G MULLER W LUSCIETI P PASSEGA E PEDRINIS E REY P MARTINOLI S SPINELLI A GALFETTI MA LOMBARDI A PEDRAZZINI A LOSA G VARINI M GINIER M HERRMANN R HARDER JF LAFFER U ALMENDRAL AC EPPENBERGER U TORHORST J SIEGENTHALER P PIGUET D BARRELET V BAUMANN RP JOSS R SAUTER C METZGER U ENGELER V HALLER U KOCHLI O LEYVRAZ S PEREY L ANANI P GOMEZ F MIRIMANOFF RO CHAPUIS G DEGRANDI P REYMOND P ALBERTO P SCHAFER P KRAUER F FORNI M AAPRO M EGELI R MEGEVAND R JACOTDESCOMBES E SCHINDLER A NOSEDA G WEBER W LEHMANN W
Citation: M. Castiglionegertsch et al., EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1385-1394

Authors: SCHMID HP MAIBACH R BERNHARD J HERING F HANSELMANN S GUSSET H MORANT R PESTALOZZI D CASTIGLIONE M
Citation: Hp. Schmid et al., A PHASE-II STUDY OF ORAL IDARUBICIN AS A TREATMENT FOR METASTATIC HORMONE-REFRACTORY PROSTATE CARCINOMA WITH SPECIAL FOCUS ON PROSTATE-SPECIFIC ANTIGEN DOUBLING TIME, Cancer, 79(9), 1997, pp. 1703-1709

Authors: WEBER W MAIBACH R LAFFER U METZGER U EGELI R LORENZ M AEBERHARD P DUPONTLAMPERT V NOTHIGER F RUEDI T CASTIGLIONE M
Citation: W. Weber et al., EARLY HEMATOLOGICAL TOXICITY OF ADJUVANT PERIOPERATIVE INTRAPORTAL AND INTRAVENOUS CHEMOTHERAPY WITH FLUOROURACIL, MITOMYCIN AND HEPARIN INCOLORECTAL-CANCER, Anticancer research, 15(5), 1995, pp. 2197-2200

Authors: GOLDHIRSCH A LAFFER UT METZGER U AEBERHARD P MAIBACH R CASTIGLIONE M
Citation: A. Goldhirsch et al., ADJUVANT INTRAPORTAL CHEMOTHERAPY FOR COLORECTAL-CANCER - REPLY, Lancet, 345(8958), 1995, pp. 1184-1184

Authors: MULLER UR DUDLER T SCHNEIDER T CRAMERI R FISCHER H SKRBIC D MAIBACH R BLASER K SUTER M
Citation: Ur. Muller et al., TYPE-I SKIN REACTIVITY TO NATIVE AND RECOMBINANT PHOSPHOLIPASE A(2) FROM HONEYBEE VENOM IS SIMILAR, Journal of allergy and clinical immunology, 96(3), 1995, pp. 395-402

Authors: ZEHNDER D KUNZI UP MAIBACH R ZOPPI M HALTER F NEFTEL KA MULLER U GALEAZZI RL HESS T HOIGNE R
Citation: D. Zehnder et al., CHDM - FREQUENCY OF ANTIBIOTIC-ASSOCIATED COLITIS IN HOSPITALIZED-PATIENTS 1974-1991, Schweizerische medizinische Wochenschrift, 125(14), 1995, pp. 676-683

Authors: WIDMER P MAIBACH R KUNZI UP CAPAUL R MUELLER U GALEAZZI R HOIGNE R
Citation: P. Widmer et al., DIURETIC-RELATED HYPOKALEMIA - THE ROLE OF DIURETICS, POTASSIUM SUPPLEMENTS, GLUCOCORTICOIDS AND BETA(2)-ADRENOCEPTOR AGONISTS - RESULTS FROM THE COMPREHENSIVE HOSPITAL DRUG-MONITORING PROGRAM, BERNE (CHDM), European Journal of Clinical Pharmacology, 49(1-2), 1995, pp. 31-36

Authors: WERNLI M FEY MF TOBLER A VONROHR A BARGETZI M TICHELLI A FEHR J GMUR J JACKY E BERIS P CHAPUIS B HESS U DELACRETAZ F JOTTERAND M SCHAPIRA M CAVALLI F MAIBACH R RUFENER B GRATWOHL A
Citation: M. Wernli et al., THE LIMIT OF DOSE-INTENSIFICATION IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA DESPITE GROWTH-FACTOR THERAPY, Blood, 84(10), 1994, pp. 10000144-10000144
Risultati: 1-14 |